The DOI matches its Crossref record; 357 of the 357 references it cites were found in a registry or an index.
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Self-citationHeart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Research works printed but not linked: 77
- Whelton, 2018, Circulation, 71, e13
- Gibbons, 2013, The next steps in developing clinical practice guidelines for prevention, Circulation, 128, 1716, 10.1161/CIRCULATIONAHA.113.005548 · DOI
- Gibbons, 2013, Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute, Circulation, 128, 1713, 10.1161/CIRCULATIONAHA.113.004587 · DOI
- 2013, Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- Rapsomaniki, 2014, Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people, Lancet, 383, 1899, 10.1016/S0140-6736(14)60685-1 · DOI · Paper page
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- Rapsomaniki, 2014, Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people, Lancet, 383, 1899, 10.1016/S0140-6736(14)60685-1 · DOI · Paper page
- Mancia, 2013, 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 34, 2159, 10.1093/eurheartj/eht151 · DOI · Paper page
- Mancia, 2013, 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 34, 2159, 10.1093/eurheartj/eht151 · DOI · Paper page
- Calhoun, 2008, Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Hypertension, 51, 1403, 10.1161/HYPERTENSIONAHA.108.189141 · DOI · Paper page
- Funder, 2016, The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 101, 1889, 10.1210/jc.2015-4061 · DOI · Paper page
- Lenders, 2014, Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 99, 1915, 10.1210/jc.2014-1498 · DOI · Paper page
- Cortese, 2013, Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol, Psychiatry, 54, 227
- Willey, 2014, Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study, J Am Heart Assoc, 3
- Mancia, 2013, 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 34, 2159, 10.1093/eurheartj/eht151 · DOI · Paper page
- Appel, 2003, Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial, JAMA, 289, 2083
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, 10.1136/bmj.b1665 · DOI · Paper page
- Ettehad, 2016, Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis, Lancet, 387, 957, 10.1016/S0140-6736(15)01225-8 · DOI · Paper page
- Sundstrom, 2014, Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data, Lancet, 384, 591, 10.1016/S0140-6736(14)61212-5 · DOI · Paper page
- Thomopoulos, 2014, Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels–overview and meta-analyses of randomized trials, J Hypertens, 32, 2296, 10.1097/HJH.0000000000000379 · DOI · Paper page
- Sundstrom, 2015, Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis, Ann Intern Med, 162, 184, 10.7326/M14-0773 · DOI · Paper page
- Xie, 2015, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis, Lancet, 387, 435, 10.1016/S0140-6736(15)00805-3 · DOI · Paper page
- Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- van Dieren, 2012, Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes, Diabetes Res Clin Pract, 98, 83, 10.1016/j.diabres.2012.05.002 · DOI
- Goff, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129(suppl 2), S49, 10.1161/01.cir.0000437741.48606.98 · DOI · Paper page
- Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129(suppl 2), S1, 10.1161/01.cir.0000437738.63853.7a · DOI · Paper page
- Chobanian, 2003, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, 42, 1206, 10.1161/01.HYP.0000107251.49515.c2 · DOI · Paper page
- Xie, 2015, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis, Lancet, 387, 435, 10.1016/S0140-6736(15)00805-3 · DOI · Paper page
- Lawes, 2002, Blood pressure and coronary heart disease: a review of the evidence, Semin Vasc Med, 2, 355, 10.1055/s-2002-36765 · DOI
- Reboussin, 2018, Circulation, 71, e116
- Ambrosius, 2014, The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT), Clin Trials, 11, 532, 10.1177/1740774514537404 · DOI · Paper page
- Cushman, 2007, Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, Am J Cardiol, 99, 44i, 10.1016/j.amjcard.2007.03.005 · DOI · Paper page
- Ambrosius, 2014, The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT), Clin Trials, 11, 532, 10.1177/1740774514537404 · DOI · Paper page
- Cushman, 2007, Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, Am J Cardiol, 99, 44i, 10.1016/j.amjcard.2007.03.005 · DOI · Paper page
- Margolis, 2013, Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial, JAMA, 310, 46, 10.1001/jama.2013.6549 · DOI · Paper page
- Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 128, e240, 10.1161/CIR.0b013e31829e8807 · DOI · Paper page
- Fihn, 2014, Circulation, 130, 1749, 10.1161/CIR.0000000000000095 · DOI · Paper page
- Gerhard-Herman, 2017, 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 135, e726, 10.1161/CIR.0000000000000471 · DOI · Paper page
- Wright, 2015, A randomized trial of intensive versus standard blood-pressure control. SPRINT Research Group, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939 · DOI · Paper page
- Bundy, 2017, Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis, JAMA Cardiol, 2, 775, 10.1001/jamacardio.2017.1421 · DOI · Paper page
- Fihn, 2014, Circulation, 130, 1749, 10.1161/CIR.0000000000000095 · DOI · Paper page
- Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, 10.1136/bmj.b1665 · DOI · Paper page
- Thomopoulos, 2016, Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials, J Hypertens, 34, 613, 10.1097/HJH.0000000000000881 · DOI · Paper page
- Xie, 2015, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis, Lancet, 387, 435, 10.1016/S0140-6736(15)00805-3 · DOI · Paper page
- Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 128, e240, 10.1161/CIR.0b013e31829e8807 · DOI · Paper page
- Lv, 2013, Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis, CMAJ, 185, 949, 10.1503/cmaj.121468 · DOI · Paper page
- Wright, 2015, A randomized trial of intensive versus standard blood-pressure control. SPRINT Research Group, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939 · DOI · Paper page
- Wang, 2016, Comparative effectiveness of blood pressure-lowering drugs in patients who have already suffered from stroke: traditional and Bayesian network meta-analysis of randomized trials, Medicine (Baltimore), 95
- Thompson, 2011, Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis, JAMA, 305, 913, 10.1001/jama.2011.250 · DOI · Paper page
- Zanchetti, 2006, Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial, J Hypertens, 24, 2163, 10.1097/01.hjh.0000249692.96488.46 · DOI · Paper page
- Xie, 2015, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis, Lancet, 387, 435, 10.1016/S0140-6736(15)00805-3 · DOI · Paper page
- Lv, 2013, Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis, CMAJ, 185, 949, 10.1503/cmaj.121468 · DOI · Paper page
- Turnbull, 2005, Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials, Arch Intern Med, 165, 1410, 10.1001/archinte.165.12.1410 · DOI · Paper page
- Leenen, 2006, Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial, Hypertension, 48, 374, 10.1161/01.HYP.0000231662.77359.de · DOI · Paper page
- Wright, 2009, ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses, Arch Intern Med, 169, 832, 10.1001/archinternmed.2009.60 · DOI
- Wright, 2008, Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Arch Intern Med, 168, 207, 10.1001/archinternmed.2007.66 · DOI · Paper page
- Wright, 2015, A randomized trial of intensive versus standard blood-pressure control. SPRINT Research Group, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939 · DOI · Paper page
- Wright, 2002, Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial, JAMA, 288, 2421, 10.1001/jama.288.19.2421 · DOI · Paper page
- Turnbull, 2008, Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials, Eur Heart J, 29, 2669, 10.1093/eurheartj/ehn427 · DOI · Paper page
- Turnbull, 2008, Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials, Eur Heart J, 29, 2669, 10.1093/eurheartj/ehn427 · DOI · Paper page
- 2013, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122
- Calhoun, 2008, Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Hypertension, 51, 1403, 10.1161/HYPERTENSIONAHA.108.189141 · DOI · Paper page
- Artinian, 2010, Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association, Circulation, 122, 406, 10.1161/CIR.0b013e3181e8edf1 · DOI · Paper page
- Eckel, 2014, 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129(suppl 1), S76, 10.1161/01.cir.0000437740.48606.d1 · DOI · Paper page
- Jaffe, 2013, Improved blood pressure control associated with a large-scale hypertension program, JAMA, 310, 699, 10.1001/jama.2013.108769 · DOI · Paper page
- Carter, 2009, The potency of team-based care interventions for hypertension: a meta-analysis, Arch Intern Med, 169, 1748, 10.1001/archinternmed.2009.316 · DOI · Paper page
- Proia, 2014, Team-based care and improved blood pressure control: a community guide systematic review, Am J Prev Med, 47, 86, 10.1016/j.amepre.2014.03.004 · DOI · Paper page
- Thomas, 2014, Check it, change it: a community-based, multifaceted intervention to improve blood pressure control, Circ Cardiovasc Qual Outcomes, 7, 828, 10.1161/CIRCOUTCOMES.114.001039 · DOI
- Jaffe, 2013, Improved blood pressure control associated with a large-scale hypertension program, JAMA, 310, 699, 10.1001/jama.2013.108769 · DOI · Paper page
- Agarwal, 2011, Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis, Hypertension, 57, 29, 10.1161/HYPERTENSIONAHA.110.160911 · DOI · Paper page
- Smith, 2011, AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation, Circulation, 124, 2458, 10.1161/CIR.0b013e318235eb4d · DOI · Paper page
- Fihn, 2014, Circulation, 130, 1749, 10.1161/CIR.0000000000000095 · DOI · Paper page
- Fihn, 2012, Circulation, 126, e354, 10.1161/CIR.0b013e318277d6a0 · DOI · Paper page
- Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 128, e240, 10.1161/CIR.0b013e31829e8807 · DOI · Paper page
- 2016, Standards of Medical Care in Diabetes–2016: Summary of Revisions, Diabetes Care, 39, S4
Cited by
Zhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,521
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Williamson (2019) · doi:10.1001/jama.2018.21442 · Cited by 1,246
Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline
Muntner, P., Carey, R. M., Gidding, S., Jones, D. W., Taler, S. J., Wright, J. T., & Whelton, P. K. (2018) · Circulation · doi:10.1161/circulationaha.117.032582 · Cited by 942
Self-citationSmart wearable devices in cardiovascular care: Where we are and how to move forward
Bayoumy, K., Gaber, M., Elshafeey, A., Mhaimeed, O., Dineen, E. H., Marvel, F. A., Martin, S. S., Muse, E. D., Turakhia, M. P., Tarakji, K. G., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00522-7 · Cited by 829
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0065 · Cited by 649
Self-citationIdiopathic intracranial hypertension: consensus guidelines on management
Mollan, S. P., Davies, B., Silver, N. C., Shaw, S., Mallucci, C. L., Wakerley, B. R., Krishnan, A., Chavda, S. V., Ramalingam, S., Edwards, J., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317440 · Cited by 612
Epidemiology of Peripheral Artery Disease and Polyvascular Disease
Aday, A. W., & Matsushita, K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318535 · Cited by 599
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
Filippou, C. D., Tsioufis, C. P., Thomopoulos, C. G., Mihas, C. C., Dimitriadis, K. S., Sotiropoulou, L. I., Chrysochoou, C. A., Nihoyannopoulos, P. I., & Tousoulis, D. M. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa041 · Cited by 539
Neurovascular and Cognitive Dysfunction in Hypertension: Epidemiology, Pathobiology, and Treatment
Iadecola, C., & Gottesman, R. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.313260 · Cited by 502
Hypertension in older adults: Assessment, management, and challenges
Oliveros, E., Patel, H., Kyung, S., Fugar, S., Goldberg, A., Madan, N., & Williams, K. A. (2020) · Clinical Cardiology · doi:10.1002/clc.23303 · Cited by 496
Self-citationMaj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
King, W. C., Hinerman, A. S., Belle, S. H., Wahed, A. S., & Courcoulas, A. P. (2018) · JAMA · doi:10.1001/jama.2018.14433 · Cited by 414
The Burden of Cardiovascular Diseases Among US States, 1990-2016
Global Burden of Cardiovascular Diseases Collaboration, Roth, G. A., Johnson, C. O., Abate, K. H., Abd-Allah, F., Ahmed, M., Alam, K., Alam, T., Alvis-Guzman, N., Ansari, H., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0385 · Cited by 389
Staerk, L., Wang, B., Preis, S. R., Larson, M. G., Lubitz, S. A., Ellinor, P. T., McManus, D. D., Ko, D., Weng, L.-C., Lunetta, K. L., et al. (2018) · BMJ · doi:10.1136/bmj.k1453 · Cited by 374
Pathophysiology of Hypertension: The Mosaic Theory and Beyond
Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021) · Circulation Research · doi:10.1161/circresaha.121.318082 · Cited by 365
Suchard, M. A., Schuemie, M. J., Krumholz, H. M., You, S. C., Chen, R., Pratt, N., Reich, C. G., Duke, J., Madigan, D., Hripcsak, G., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32317-7 · Cited by 359
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women
Cho, L., Davis, M., Elgendy, I., Epps, K., Lindley, K. J., Mehta, P. K., Michos, E. D., Minissian, M., Pepine, C., Vaccarino, V., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.060 · Cited by 347
Left ventricular hypertrophy and hypertension
Yildiz, M., Oktay, A. A., Stewart, M. H., Milani, R. V., Ventura, H. O., & Lavie, C. J. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.11.009 · Cited by 333
Kario, K., Hoshide, S., Mizuno, H., Kabutoya, T., Nishizawa, M., Yoshida, T., Abe, H., Katsuya, T., Fujita, Y., Okazaki, O., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.049730 · Cited by 324
Wilson, R. D., Caughey, A. B., Wood, S. L., Macones, G. A., Wrench, I. J., Huang, J., Norman, M., Pettersson, K., Fawcett, W. J., Shalabi, M. M., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.09.015 · Cited by 315
Lifestyle Strategies for Risk Factor Reduction, Prevention, and Treatment of Cardiovascular Disease
Rippe, J. M. (2019) · American Journal of Lifestyle Medicine · doi:10.1177/1559827618812395 · Cited by 312
Hypertension and Stroke: Update on Treatment
Wajngarten, M., & Silva, G. S. (2019) · European Cardiology Review · doi:10.15420/ecr.2019.11.1 · Cited by 304
Semlitsch, T., Stigler, F. L., Jeitler, K., Horvath, K., & Siebenhofer, A. (2019) · Obesity Reviews · doi:10.1111/obr.12889 · Cited by 298
Zhang, L.-K., Sun, Y., Zeng, H., Wang, Q., Jiang, X., Shang, W.-J., Wu, Y., Li, S., Zhang, Y.-L., Hao, Z.-N., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00235-0 · Cited by 298
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285
Edwards, J. J., Deenmamode, A. H. P., Griffiths, M., Arnold, O., Cooper, N. J., Wiles, J. D., & O'Driscoll, J. M. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106503 · Cited by 284
Potassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
Filippini, T., Naska, A., Kasdagli, M., Torres, D., Lopes, C., Carvalho, C., Moreira, P., Malavolti, M., Orsini, N., Whelton, P. K., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015719 · Cited by 271
Self-citationMediterranean diet nutrients to turn the tide against insulin resistance and related diseases
Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272
Emerging trends in hypertension epidemiology in India
Gupta, R., Gaur, K., & S. Ram, C. V. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-018-0117-3 · Cited by 269
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
Hall, J. E., Mouton, A. J., da Silva, A. A., Omoto, A. C. M., Wang, Z., Li, X., & do Carmo, J. M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa336 · Cited by 265
Hypertension in pregnancy: Pathophysiology and treatment
Braunthal, S., & Brateanu, A. (2019) · SAGE Open Medicine · doi:10.1177/2050312119843700 · Cited by 263
Hypertension and incident cardiovascular events following ibrutinib initiation
Dickerson, T., Wiczer, T., Waller, A., Philippon, J., Porter, K., Haddad, D., Guha, A., Rogers, K. A., Bhat, S., Byrd, J. C., et al. (2019) · Blood · doi:10.1182/blood.2019000840 · Cited by 260
Beaney, T., Burrell, L. M., Castillo, R. R., Charchar, F. J., Cro, S., Damasceno, A., Kruger, R., Nilsson, P. M., Prabhakaran, D., Ramirez, A. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz300 · Cited by 255
Luo, D., Cheng, Y., Zhang, H., Ba, M., Chen, P., Li, H., Chen, K., Sha, W., Zhang, C., & Chen, H. (2020) · BMJ · doi:10.1136/bmj.m3222 · Cited by 234
Spectral Analysis of Heart Rate Variability: Time Window Matters
Li, K., Rüdiger, H., & Ziemssen, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00545 · Cited by 215
Bhanpuri, N. H., Hallberg, S. J., Williams, P. T., McKenzie, A. L., Ballard, K. D., Campbell, W. W., McCarter, J. P., Phinney, S. D., & Volek, J. S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0698-8 · Cited by 190
Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research
Muntner, P., Einhorn, P. T., Cushman, W. C., Whelton, P. K., Bello, N. A., Drawz, P. E., Green, B. B., Jones, D. W., Juraschek, S. P., Margolis, K. L., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.069 · Cited by 199
Self-citationPaluch, A. E., Gabriel, K. P., Fulton, J. E., Lewis, C. E., Schreiner, P. J., Sternfeld, B., Sidney, S., Siddique, J., Whitaker, K. M., & Carnethon, M. R. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.24516 · Cited by 175
Groeneweg, S., Peeters, R. P., Moran, C., Stoupa, A., Auriol, F., Tonduti, D., Dica, A., Paone, L., Rozenkova, K., Malikova, J., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30155-x · Cited by 129
Murphy, D. P., Drawz, P. E., & Foley, R. N. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018100971 · Cited by 106
Leal, J. M., Galliano, L. M., & Del Vecchio, F. B. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1030-z · Cited by 105
Egan, B. M., Sutherland, S. E., Rakotz, M., Yang, J., Hanlin, R. B., Davis, R. A., & Wozniak, G. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11558 · Cited by 104
Cuffless Blood Pressure Monitoring: Promises and Challenges
Pandit, J. A., Lores, E., & Batlle, D. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03680320 · Cited by 101
Anstey, D. E., Muntner, P., Bello, N. A., Pugliese, D. N., Yano, Y., Kronish, I. M., Reynolds, K., Schwartz, J. E., & Shimbo, D. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11319 · Cited by 85
Self-citationEmergence of Home Blood Pressure-Guided Management of Hypertension Based on Global Evidence
Kario, K., Shimbo, D., Hoshide, S., Wang, J.-G., Asayama, K., Ohkubo, T., Imai, Y., McManus, R. J., Kollias, A., Niiranen, T. J., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12630 · Cited by 82
Self-citationMindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 single-arm clinical trial
Loucks, E. B., Nardi, W. R., Gutman, R., Kronish, I. M., Saadeh, F. B., Li, Y., Wentz, A. E., Webb, J., Vago, D. R., Harrison, A., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223095 · Cited by 60
Dorsch, M. P., Lester, C. A., Ding, Y., Joseph, M., & Brook, R. D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.014709 · Cited by 50
Rahman, F., McEvoy, J. W., Ohkuma, T., Marre, M., Hamet, P., Harrap, S., Mancia, G., Rodgers, A., Selvin, E., Williams, B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12414 · Cited by 48
Self-citationIlkun, O. L., Greene, T., Cheung, A. K., Whelton, P. K., Wei, G., Boucher, R. E., Ambrosius, W., Chertow, G. M., & Beddhu, S. (2020) · Diabetes Care · doi:10.2337/dc19-2047 · Cited by 46
Self-citationNardi, W. R., Harrison, A., Saadeh, F. B., Webb, J., Wentz, A. E., & Loucks, E. B. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239533 · Cited by 43
Treatment of Oxidative Stress with Exosomes in Myocardial Ischemia
Liu, Y., Wang, M., Liang, Y., Wang, C., Naruse, K., & Takahashi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041729 · Cited by 42
Babcock, M. C., Robinson, A. T., Migdal, K. U., Watso, J. C., Wenner, M. M., Stocker, S. D., & Farquhar, W. B. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12074 · Cited by 40
Beran, M., Asche, S. E., Bergdall, A. R., Crabtree, B., Green, B. B., Groen, S. E., Klotzle, K. J., Michels, R. D., Nyboer, R. A., O'Connor, P. J., et al. (2018) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2018.07.001 · Cited by 32
Kovell, L. C., Yeung, E. H., Miller, E. R., Appel, L. J., Christenson, R. H., Rebuck, H., Schulman, S. P., & Juraschek, S. P. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.102 · Cited by 27
Vongpatanasin, W., Ayers, C., Lodhi, H., Das, S. R., Berry, J. D., Khera, A., Victor, R. G., Lin, F.-C., Viera, A. J., Yano, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11657 · Cited by 24
Wilson, R. D., Monks, D. T., Sharawi, N., Bamber, J., Panelli, D. M., Sauro, K. M., Shah, P. S., Muraca, G. M., Metcalfe, A., Wood, S. L., et al. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.01.014 · Cited by 22
White, W. B., Jalil, F., Cushman, W. C., Bakris, G. L., Bergenstal, R., Heller, S. R., Liu, Y., Mehta, C., Zannad, F., & Cannon, C. P. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009114 · Cited by 22
Chichetto, N. E., Kundu, S., Freiberg, M. S., Koethe, J. R., Butt, A. A., Crystal, S., So-Armah, K. A., Cook, R. L., Braithwaite, R. S., Justice, A. C., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03327-4 · Cited by 20
High body fat percentage is associated with primary aldosteronism: a cross-sectional study
Manosroi, W., & Atthakomol, P. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00654-w · Cited by 18
Mapesi, H., Gupta, R., Wilson, H. I., Lukau, B., Amstutz, A., Lyimo, A., Muhairwe, J., Senkoro, E., Byakuzana, T., Mphunyane, M., et al. (2021) · Trials · doi:10.1186/s13063-021-05023-z · Cited by 8
Metadata
- Authors
- Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Williamson, J. D., & Wright, J. T.
- Venue
- Journal of the American Society of Hypertension
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 12
- Issue
- 8
- Pages
- 579.e1-579.e73
- ISSN
- 1878-7436 (ISSN-L)
- 1933-1711
- OpenAlex
- W3138221603
- Cited by
- 947
- References
- 357
- FWCI
- 152.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.